Find clinical trials for Non-Small-Cell Lung Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Atlanta, GA, USA:
, HER3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous...
Phase 1
Atlanta, Georgia, United States and 21 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Lawrenceville, Georgia, United States and 137 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Dunwoody, Georgia, United States and 123 other locations
This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...
Phase 2
Atlanta, Georgia, United States and 157 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Atlanta, Georgia, United States and 210 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Atlanta, Georgia, United States and 168 other locations
and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non...
Phase 3
Atlanta, Georgia, United States and 118 other locations
This is a Phase I open label multi-center study to evaluate the safety, tolerability, pharmacokinetics and preliminary effectiveness of the investiga...
Phase 1
Atlanta, Georgia, United States and 55 other locations
, early-stage non-small cell lung cancer....
Phase 2
Gainesville, Georgia, United States and 94 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Marietta, Georgia, United States and 262 other locations
Clinical trials
Research sites
Resources
Legal